Investigadores
Inicio
Investigadores
Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca.
Inmunoterapia Celular
Terapia con células somáticas
Innovaciones Tecnológicas y Biomodelos
FERMÍN SÁNCHEZ-GUIJO MARTÍN
Investigador principal
Grupo de Investigación: Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca.
Julia Barbado Ajo
Investigador colaborador
Grupo de Investigación: Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca.
Margarita Calonge Cano
Investigador colaborador
Grupo de Investigación: Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca.
Marina López Paniagua
Investigador colaborador
Grupo de Investigación: Instituto de Investigación Biomédica de Salamanca (IBSAL). Salamanca.
Sánchez-González J.L., Fernández-Rodríguez E.J., Méndez-Sánchez R., Polo-Ferrero L., Puente-González S., de Ramón C., Marcos-Asensio S., Blázquez-Benito P., Baile-González M., Navarro-Bailón A., Sánchez-Guijo F., Martín-Vallejo J., Perez J., Martín-Sánchez C.. A pilot randomized trial of supervised resistance training plus home-based activity in chronic lymphocytic leukaemia patients. Scientific Reports. December 2026. DOI: 10.1038/s41598-026-38721-2.
Impacto: 3.9. Cuartil: Q1
Jordana-Urriza L., Serrano G., Camara-Peña S., Calleja-Cervantes M.E., San Martin-Uriz P., Zabaleta A., Oliver-Caldes A., Español-Rego M., Alignani D., Lozano T., Rodriguez-Diaz S., Iglesias E., Cabañas V., Reguera J.L., Gonzalez-Calle V., Mateos M.V., Sanchez-Guijo F., Paiva B., Lasarte J.J., Inoges S., Lopez-Diaz de Cerio A., Gonzalez-Navarro A., Juan M., Fernandez de Larrea C., Tamariz E., Alfonso-Pierola A., Rodriguez-Otero P., San-Miguel J.F., Hernaez M., Rodriguez-Madoz J.R., Prosper F.. Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma. Blood Neoplasia. May 2026. DOI: 10.1016/j.bneo.2026.100203.
Pello O.M., Martinez-Muñoz M.E., Arroyo J.L., Fernandez-Sojo J., Sureda A., Sanchez-Guijo F.. Impact of the national blackout of April 28, 2025 on processing facilities for hematopoietic stem cell transplantation and cell therapy in Spain. Transfusion and Apheresis Science. December 2025. DOI: 10.1016/j.transci.2025.104257.
Impacto: 1.2. Cuartil: Q4
Gutiérrez-Herrero S., Martín-Martín L., Herrero-García M., Puertas B., da Silva Barbosa E., Mateos M.V., López-Corral L., González-Calle V., Rey-Búa B., Martín-López A.Á., Pérez-López E., Sánchez-Guijo F., López-Parra M., Puig N., Orfao A.. Impact of the kinetics of circulating anti-BCMA CAR-T cells and normal lymphocytes on the outcome of MM patients. Hemasphere. December 2025. DOI: 10.1002/hem3.70277.
Impacto: 14.6. Cuartil: Q1
(1er decil)
Martí-Chillón G.J., Muntión S., Flores-Montero J., González-Robledo J., Corchete L., Pozo J., Osugui L., Preciado S., Gómez-Redondo M., Blanco J.F., Navarro-Bailón A., Sagredo V., Almeida J., Orfao A., Sánchez-Guijo F.. Immune cell dynamics, cytokines, and extracellular vesicles in systemic inflammatory response syndrome (SIRS): a multiparametric analysis. Journal of Translational Medicine. December 2025. DOI: 10.1186/s12967-025-07327-z.
Impacto: 7.5. Cuartil: Q1
Caballero-Velázquez T., Delgado Serrano J., López-Corral L., Ferra-Coll C., García-Calderón C.B., Valcárcel D., García-Cadenas I., Pérez López E., Jiménez Lorenzo M.J., Martín-Domínguez F.M., Jiménez-León M.d.l.R., Orti G., Escamilla Gómez V., Blázquez-Goñi C., Cabero Martínez A., Andrade Ruiz H., Menéndez-Pedregal E., Sánchez-Guijo F., Pérez Simón J.A.. Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGVHD biomarkers. Blood Advances. 11 November 2025. DOI: 10.1182/bloodadvances.2025016284.
Impacto: 7.1. Cuartil: Q1
Davies L.C., Biard L., García-Olmo D., Gilkeson G., Gnecchi M., Kurtzberg J., Kogler G., Blanc K.L., Lowdell M.W., Pers Y.M., Sun L.y., Tarte K., Uccelli A., Sanchez-Guijo F., Farge D.. Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases. Cytotherapy. November 2025. DOI: 10.1016/j.jcyt.2025.06.005.
Impacto: 3.2. Cuartil: Q2
McLornan D.P., Hazenberg M.D., Ciceri F., Alexander T., Angelucci E., Averbuch D., Bazarbachi A., Chakraverty R., Booth C., Heemskerk M.H.M., Holler E., Kalwak K., Kenyon M., Ljungman P., Miccio A., Neven B., Pagliuca S., Peric Z., Risitano A., Ruggeri A., Sánchez-Guijo F., de Silva T., Snowden J.A., Socie G., Steinbuch M., Vago L., Greco R., Sánchez-Ortega I., Sureda A.. Advancing the Integration of ‘Basic/Fundamental’ and Translational Cellular and Gene Therapy Science within the EBMT: Accelerating the Pathway to Progress. Bone Marrow Transplantation. October 2025. DOI: 10.1038/s41409-025-02688-x.
Impacto: 5.2. Cuartil: Q1
Arias-Hidalgo C., Juanes-Velasco P., Iglesia-Sánchez A., Nuño-Soriano A., Lecrevisse Q., Herrero R., Ferruelo A., Douhal Y., Wang H., Zhang X., Telleria P., K.J. Pieren D., van Els C.A.C.M., López-Parra M., Sánchez-Guijo F., Góngora R., Montalvillo E., Sánchez-Santos J.M., De Las Rivas J., Bernardo D., Lorente J.A., Wang Y., Yu X., Hernández A.P., Fuentes M.. Humoral Response Profile in SARS-CoV-2 Infection: Differences across Virus Strains and Influenza. Journal of Proteome Research. 5 September 2025. DOI: 10.1021/acs.jproteome.4c00935.
Impacto: 3.6. Cuartil: Q2
Gil-Manso R., Hidalgo Calleja C., Puebla Tornero L., Cabero-Martínez A., García-Bacelar A., Martín López A.Á., Cabrero M., Baile M., Pérez-López E., Avendaño Pita A., Vázquez López L., Alonso Rodríguez J., Gilabert Gutiérrez M.d.C., Sánchez-Guijo F., López-Corral L.. Nabiximols oromucosal spray in patients with chronic graft-versus-host disease: effects on sclerodermatous features and refractory muscle cramps. Bone Marrow Transplantation. September 2025. DOI: 10.1038/s41409-025-02665-4.
Impacto: 5.2. Cuartil: Q1
Niño-Ramírez J.E., Gil-Etayo F.J., Fonseca-Santos M., López-Pérez J., Jiménez Hernaz I., Vicente Parra A., Terradillos Sánchez P., Calzada N., Boix F., Marín L., Arroyo-Sánchez D., Alcoceba M., Navarro-Bailón A., Peña-Muñoz F., Marcos Asensio S., Pérez-López E., Vázquez L., Sánchez-Guijo F., García-Sanz R., López-Corral L., Tejeda Velarde A.. NK Alloreactivity Evaluation According to KIR-HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem-Cell Transplantation Based on Post-Transplant Cyclophosphamide. Hla. August 2025. DOI: 10.1111/tan.70340.
Impacto: 4.1. Cuartil: Q1
Tan E.H., Aljurf M., Hussain F., Chabannon C., Worel N., Weisdorf D., Yakoub-Agha I., Galeano S., Sanchez-Guijo F., Garderet L., Atsuta Y., Ruggeri A., Hamad N., Hashmi S., Frutos C., Kodera Y., Seber A., Bonfim C., Niederwieser D., Rondelli D., Greinix H., Koh M.B.. Perspectives on the use and availability of chimeric antigen receptor T cells (CAR-T) and cell therapies: A worldwide cross-sectional survey by the worldwide network for blood and marrow transplantation (WBMT). Current Research in Translational Medicine. 1 April 2025. DOI: 10.1016/j.retram.2025.103515.
Impacto: 3.2. Cuartil: Q2
Diez B., Calviño C., Fernández-García M., Rodríguez-Márquez P., Rodríguez-Díaz S., Martínez-Turillas R., Ceballos C., Illarramendi J., Serrano-López J., Miskey C., Navarro-Bailón A., López-Corral L., Llamas P., Redondo M., Sánchez-Guijo F., Rifon J., Alfonso-Piérola A., Ivics Z., Inogés S., López-Díaz de Cerio A., Yanez R., Bueren J.A., Rodríguez-Madoz J.R., Prosper F.. Generation and GMP scale-up of human CAR-T cells using non-viral Sleeping Beauty transposons for B cell malignances. Molecular Therapy Methods and Clinical Development. 13 March 2025. DOI: 10.1016/j.omtm.2025.101425.
Sánchez-Guijo F., Jiménez S.. Initial achievements and remaining challenges of CAR-T cell therapy in the Spanish National Health System. Farmacia Hospitalaria. 1 March 2025. DOI: 10.1016/j.farma.2025.02.004.
Lamo-Espinosa J.M., Suárez-López del Amo Á., Núñez-Córdoba J.M., Blanco J.F., Sánchez M., Moreno V., Cabrera M., Granero-Moltó F., Muiños E., Mazo M.M., Crespo-Cullell Í., Mora G., Delgado D., Pompei-Fernández O., Aquerreta J.D., Sola M.V., Valentí-Azcárate A., Andreu E.J., López-Parra M., Villarón E.M., Valentí-Nin J.R., Sánchez-Guijo F., Prósper F.. Effect of Hyaluronic Acid Compared to Platelet-Rich Plasma as Adjuvants to Bone Marrow Mesenchymal Stem Cell Treatment of Knee Osteoarthritis: Analysis from Two Clinical Trials. Diagnostics. February 2025. DOI: 10.3390/diagnostics15030309.
Impacto: 3.0. Cuartil: Q1
Valencia J., Yáñez R.M., Muntión S., Fernández-García M., Martín-Rufino J.D., Zapata A.G., Bueren J.A., Vicente Á., Sánchez-Guijo F.. Improving the therapeutic profile of MSCs: Cytokine priming reduces donor-dependent heterogeneity and enhances their immunomodulatory capacity. Frontiers in Immunology. 2025. DOI: 10.3389/fimmu.2025.1473788.
Impacto: 5.7. Cuartil: Q1
Sánchez-González J.L., Fernández-Rodríguez E.J., Méndez-Sánchez R., Polo-Ferrero L., Puente-González A.S., de Ramón C., Marcos-Asensio S., Blázquez-Benito P., Navarro-Bailón A., Sánchez-Guijo F., Martín-Sánchez C.. Effects of a strength physical exercise program in chronic lymphocytic leukemia patients on quality of life, mental health, and frailty: a randomized controlled trial study protocol. Frontiers in Sports and Active Living. 2025. DOI: 10.3389/fspor.2025.1534861.
Lopez-Corral L., Blázquez-Goñi C., Pérez-López E., Martín-Domínguez F.M., Cabero Martínez A., Rodríguez-Torres N., Cabrero M., Espigado-Tocino I., Martín López A.A., Parody-Porras R., Baile González M., Caballero-Velázquez T., Cortés-Rodríguez M., Soria-Saldise E., Avendaño Pita A., Alcalde-Mellado P., García Bacelar A., Rodríguez-Arbolí E., López Parra M., Falantes-González J.F., Navarro-Bailón A., Vázquez López L., Escamilla-Gómez V., Sánchez-Guijo F., Pérez-Simón J.A.. GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation. Bone Marrow Transplantation. 2025. DOI: 10.1038/s41409-025-02562-w.
Impacto: 4.5. Cuartil: Q1
Ijurko C., Romo-González M., Prieto-Bermejo R., Díez-Campelo M., Vidriales M.B., Muntión S., Sánchez-Guijo F., Sánchez-Yagüe J., Hernández-Hernández Á.. Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia. Biomarker Research. December 2024. DOI: 10.1186/s40364-024-00674-x.
Impacto: 9.5. Cuartil: Q1
(1er decil)
Martín-Martín L., Gutiérrez-Herrero S., Herrero-García M., Martín García-Sancho A., Yeguas A., Martín-López A.Á., López-Corral L., Pérez-López E., García-Blázquez M., Sánchez-Guijo F., Vidriales M.B., Gaipa G., Orfao A.. Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients. Blood Cancer Journal. December 2024. DOI: 10.1038/s41408-024-01065-z.
Impacto: 12.9. Cuartil: Q1
(1er decil)
Gil-Etayo F.J., Niño-Ramírez J.E., Fonseca-Santos M., Arroyo-Sánchez D., Navarro-Bailón A., Vicente Parra A., Jiménez Hernaz I., Terradillos Sánchez P., Boix F., Alcoceba M., Marín L., Pérez-López E., Cabrero M., Martín-López A.Á., López M., Baile M., Avendaño A., Cabero A., García-Bacelar A., Vázquez L., Sánchez-Guijo F., García-Sanz R., López-Corral L., Tejeda Velarde A.. Quantifying HLA Mismatches at Epitope Level in Haplo-HSCT: Impact in the Outcome in Strategies Using PTCy. HLA. November 2024. DOI: 10.1111/tan.15738.
Impacto: 5.9. Cuartil: Q1
(1er decil)
Muntión S., Sánchez-Luis E., Díez-Campelo M., Blanco J.F., Sánchez-Guijo F., De Las Rivas J.. Novel Gene Biomarkers Specific to Human Mesenchymal Stem Cells Isolated from Bone Marrow. International Journal of Molecular Sciences. November 2024. DOI: 10.3390/ijms252211906.
Impacto: 4.9. Cuartil: Q1
Hamad-Alrashid H., Muntión S., Sánchez-Guijo F., Borrajo-Sánchez J., Parreño-Manchado F., García-Cenador M.B., García-Criado F.J.. Bone Regeneration with Dental Pulp Stem Cells in an Experimental Model. Journal of Personalized Medicine. November 2024. DOI: 10.3390/jpm14111075.
Impacto: 3.0. Cuartil: Q1
Fernández-Sánchez A., Hernández-Sánchez A., De Ramón C., Chillón M.C., Vidriales M.B., Baile-González M., Fuentes-Morales C.T., Sierra-Pacho M., López-Corral L., Sánchez-Guijo F.. Blast Transformation of Chronic Myeloid Leukemia Driven by Acquisition of t(8;21)(q22;q22)/RUNX1::RUNX1T1: Selecting Optimal Treatment Based on Clinical and Molecular Findings. Biomedicines. October 2024. DOI: 10.3390/biomedicines12102339.
Impacto: 3.9. Cuartil: Q1
Rochate D., González-García A.M., Santos Marcos C., Pérez-López E., Martín-López A.Á., Alaña M., Martín Martín L., López Parra M., Sánchez Guijo F., López Corral L.. Autonomic dysfunction as manifestation of ICANS: A case report. Medicine (United States). 6 September 2024. DOI: 10.1097/MD.0000000000038659.
Impacto: 1.3. Cuartil: Q2
Navarro-Bailón A., López-Parra M., Veiga-Vaz Á., Villarón E.M., Díez-Campelo M., Martín A.Á., Pérez-López E., Cabrero M., Vázquez L., López-Corral L., Sánchez-Guijo F.. Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells. Cytotherapy. August 2024. DOI: 10.1016/j.jcyt.2024.04.006.
Impacto: 3.7. Cuartil: Q1
Sanchez-Guijo F., Vives J., Ruggeri A., Chabannon C., Corbacioglu S., Dolstra H., Farge D., Gagelmann N., Horgan C., Kuball J., Neven B., Rintala T., Rocha V., Sanchez-Ortega I., Snowden J.A., Zwaginga J.J., Gnecchi M., Sureda A.. Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT). Cytotherapy. July 2024. DOI: 10.1016/j.jcyt.2024.02.007.
Impacto: 3.7. Cuartil: Q1
Greco R., Alexander T., Del Papa N., Müller F., Saccardi R., Sanchez-Guijo F., Schett G., Sharrack B., Snowden J.A., Tarte K., Onida F., Sánchez-Ortega I., Burman J., Castilla Llorente C., Cervera R., Ciceri F., Doria A., Henes J., Lindsay J., Mackensen A., Muraro P.A., Ricart E., Rovira M., Zuckerman T., Yakoub-Agha I., Farge D.. Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine. March 2024. DOI: 10.1016/j.eclinm.2024.102476.
Impacto: 9.6. Cuartil: Q1
(1er decil)
Jiménez M.F., Gómez-Hernández M.T., Villarón E.M., López-Parra M., Sánchez-Guijo F.. Autologous mesenchymal stromal cells embedded with Tissucol Duo<sup>®</sup> for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Research and Therapy. December 2023. DOI: 10.1186/s13287-023-03545-8.
Impacto: 7.1. Cuartil: Q1
(1er decil)
Gomez-Ruiz V., Blanco J.F., Villarón E.M., Fidalgo H., López-Parra M., Sánchez-Guijo F.. Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial. Stem Cell Research and Therapy. December 2023. DOI: 10.1186/s13287-023-03298-4.
Impacto: 7.1. Cuartil: Q1
(1er decil)
Preciado S., Martínez-Villaluenga C., Rico D., Muntión S., García-Macías M.C., Navarro-Bailón A., Martín-Diana A.B., Sánchez-Guijo F.. Effects of Dietary Supplementation with a Ferulic Acid-Rich Bioactive Component of Wheat Bran in a Murine Model of Graft-Versus-Host Disease. Nutrients. November 2023. DOI: 10.3390/nu15214582.
Impacto: 4.8. Cuartil: Q1
Vives J., Sánchez-Guijo F., Gnecchi M., Zwaginga J.J.. Cell and gene therapy workforce development: the role of the International Society for Cell & Gene Therapy (ISCT) in the creation of a sustainable and skilled workforce in Europe. Cytotherapy. October 2023. DOI: 10.1016/j.jcyt.2023.06.006.
Impacto: 3.7. Cuartil: Q1
Rejeski K., Subklewe M., Aljurf M., Bachy E., Balduzzi A., Barba P., Bruno B., Benjamin R., Carrabba M.G., Chabannon C., Ciceri F., Corradini P., Delgado J., Di Blasi R., Greco R., Houot R., Iacoboni G., Jäger U., Kersten M.J., Mielke S., Nagler A., Onida F., Peric Z., Roddie C., Ruggeri A., Sánchez-Guijo F., Sánchez-Ortega I., Schneidawind D., Schubert M.L., Snowden J.A., Thieblemont C., Topp M., Zinzani P.L., Gribben J.G., Bonini C., Sureda A., Yakoub-Agha I.. Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations. Blood. 7 September 2023. DOI: 10.1182/blood.2023020578.
Impacto: 21.0. Cuartil: Q1
(1er decil)
Sánchez-Guijo F., Avendaño-Solá C., Badimón L., Bueren J.A., Canals J.M., Delgadillo J., Delgado J., Eguizábal C., Fernández-Santos M.E., García-Olmo D., González-Aseguinolaza G., Juan M., Martín F., Mata R., Montserrat N., Pérez-Martínez A., Pérez-Simón J.A., Prósper F., Urbano-Ispizua Á., Zapata A.G., Sureda A., Moraleda J.M.. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplantation. June 2023. DOI: 10.1038/s41409-023-01962-0.
Impacto: 4.5. Cuartil: Q1
Saccardi R., Putter H., Eikema D.J., Busto M.P., McGrath E., Middelkoop B., Adams G., Atlija M., Ayuk F.A., Baldomero H., Beguin Y., de la Cámara R., Cedillo Á., Balari A.M.S., Chabannon C., Corbacioglu S., Dolstra H., Duarte R.F., Dulery R., Greco R., Gusi A., Hamad N., Kenyon M., Kröger N., Labopin M., Lee J., Ljungman P., Manson L., Mensil F., Milpied N., Mohty M., Oldani E., Orchard K., Passweg J., Pearce R., de Latour R.P., Poirel H.A., Rintala T., Rizzo J.D., Ruggeri A., Sanchez-Martinez C., Sanchez-Guijo F., Sánchez-Ortega I., Trnková M., Ferreiras D.V., Wilcox L., de Wreede L.C., Snowden J.A.. Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation. June 2023. DOI: 10.1038/s41409-023-01924-6.
Impacto: 4.5. Cuartil: Q1
Blanco J.F., Garcia-Garcia F.J., Villarón E.M., da Casa C., Fidalgo H., López-Parra M., Santos J.A., Sánchez-Guijo F.. Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis. Journal of Clinical Medicine. March 2023. DOI: 10.3390/jcm12062117.
Impacto: 3.0. Cuartil: Q1
Ainciburu M., Ezponda T., Berastegui N., Alfonso-Pierola A., Vilas-Zornoza A., San Martin-Uriz P., Alignani D., Lamo-Espinosa J., San-Julian M., Jiménez-Solas T., Lopez F., Muntion S., Sanchez-Guijo F., Molero A., Montoro J., Serrano G., Diaz-Mazkiaran A., Lasaga M., Gomez-Cabrero D., Diez-Campelo M., Valcarcel D., Hernaez M., Romero J.P., Prosper F.. Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single-cell resolution. eLife. 11 January 2023. DOI: 10.7554/eLife.79363.
Impacto: 6.4. Cuartil: Q1
(1er decil)
Berastegui N., Ainciburu M., Romero J.P., Garcia-Olloqui P., Alfonso-Pierola A., Philippe C., Vilas-Zornoza A., San Martin-Uriz P., Ruiz-Hernández R., Abarrategi A., Ordoñez R., Alignani D., Sarvide S., Castro-Labrador L., Lamo-Espinosa J.M., San-Julian M., Jimenez T., López-Cadenas F., Muntion S., Sanchez-Guijo F., Molero A., Montoro M.J., Tazón B., Serrano G., Diaz-Mazkiaran A., Hernaez M., Huerga S., Bewicke-Copley F., Rio-Machin A., Maurano M.T., Díez-Campelo M., Valcarcel D., Rouault-Pierre K., Lara-Astiaso D., Ezponda T., Prosper F.. The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes. Nature Communications. December 2022. DOI: 10.1038/s41467-022-35192-7.
Impacto: 16.6. Cuartil: Q1
(1er decil)
Ruggeri A., Galimard J.E., Labopin M., Rafii H., Blaise D., Ciceri F., Diez-Martin J.L., Cornelissen J., Chevallier P., Sanchez-Guijo F., Nicholson E., Castagna L., Forcade E., Kuball J., Rovira M., Koc Y., Pavlu J., Gulbas Z., Vydra J., Baron F., Sanz J., Spyridonidis A., Savani B., Gluckman E., Nagler A., Mohty M.. Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Transplantation and Cellular Therapy. October 2022. DOI: 10.1016/j.jtct.2022.07.006.
Impacto: 3.2. Cuartil: Q2
Hernández-Sánchez A., Cabero A., Fonseca M., Puertas B., Gómez S., Alonso D., Alejo E., Puerta C., García P., Pablos A., Peña F., Cabrero M., Avendaño A., Baile M., Martín A.Á., Pérez E., López M., Marcos S., Prieto L., Vázquez L., Sánchez-Guijo F., Caballero M.D., López-Corral L.. CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters. Clinical Lymphoma, Myeloma and Leukemia. October 2022. DOI: 10.1016/S2152-2650(22)01653-6.
Impacto: 2.7. Cuartil: Q3
Santos M.F., Alvarez M.G., Sanchez L.A.C., Sanchez A.H., Martinez B.P., Salinero M., Rodriguez A., Martin A.A., Pita A.A., Gonzalez M.B., Cabero A., Lopez E.P., Calvo M.C., Sanchez-Guijo F., Lopez L.V., Garcia-Sanz R., Barrigon M.D.C., Alcoceba M., Lopez-Corral L., de Hematología S.. CT-195 Predictive Value of ST2, REG3a, and MAGIC Algorithm in Haploidentical Transplantation With Post-Transplant Cyclophosphamide Outcomes. Clinical Lymphoma, Myeloma and Leukemia. October 2022. DOI: 10.1016/S2152-2650(22)01654-8.
Impacto: 2.7. Cuartil: Q3
Luna A., Pérez-Lamas L., Boque C., Giraldo P., Xicoy B., Ruiz Nuño C., Vega M.M., Alvarez-Larrán A., Salamanca A., García-Noblejas A., Vall-Llovera F., Villalon L., De las Heras N., Ramila E., Pérez-Encinas M., Cuevas B., Perez-Lopez R., Sanchez-Guijo F., Jiménez-Velasco A., Lakhwani S., Casado L.F., Rosell A., Escola A., Fernández M.J., Garcia-Hernandez C., Cervero C., Mora E., Sagüés M., Suarez-Varela S., Vélez P., Carrascosa Mastell P., Bitaube R.F., Serrano L., Cortes M., Vera Goñi J.A., Steegmann J.L., de Soria V.G.G., Alonso-Dominguez J.M., Araujo M.C., Coll A.P., Hernandez-Boluda J.C., García-Gutiérrez V.. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia. Annals of Hematology. October 2022. DOI: 10.1007/s00277-022-04932-6.
Impacto: 3.5. Cuartil: Q2
Díaz-Beyá M., García-Fortes M., Valls R., Artigas L., Gómez-Casares M.T., Montesinos P., Sánchez-Guijo F., Coma M., Vendranes M., Martínez-López J.. A Systems Biology- and Machine Learning-Based Study to Unravel Potential Therapeutic Mechanisms of Midostaurin as a Multitarget Therapy on FLT3-Mutated AML. BioMedInformatics. September 2022. DOI: 10.3390/biomedinformatics2030024.
Ibáñez-Fonseca A., Rico A., Preciado S., González-Pérez F., Muntión S., García-Briñón J., García-Macías M.C., Rodríguez-Cabello J.C., Pericacho M., Alonso M., Sánchez-Guijo F.. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia. Frontiers in Bioengineering and Biotechnology. 23 June 2022. DOI: 10.3389/fbioe.2022.918602.
Impacto: 5.7. Cuartil: Q1
Fernández-Santos M.E., Garcia-Arranz M., Andreu E.J., García-Hernández A.M., López-Parra M., Villarón E., Sepúlveda P., Fernández-Avilés F., García-Olmo D., Prosper F., Sánchez-Guijo F., Moraleda J.M., Zapata A.G.. Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome. Frontiers in Immunology. 9 June 2022. DOI: 10.3389/fimmu.2022.918565.
Impacto: 7.3. Cuartil: Q1
Hayden P.J., Roddie C., Bader P., Basak G.W., Bonig H., Bonini C., Chabannon C., Ciceri F., Corbacioglu S., Ellard R., Sanchez-Guijo F., Jäger U., Hildebrandt M., Hudecek M., Kersten M.J., Köhl U., Kuball J., Mielke S., Mohty M., Murray J., Nagler A., Rees J., Rioufol C., Saccardi R., Snowden J.A., Styczynski J., Subklewe M., Thieblemont C., Topp M., Ispizua U., Chen D., Vrhovac R., Gribben J.G., Kröger N., Einsele H., Yakoub-Agha I.. Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology. March 2022. DOI: 10.1016/j.annonc.2021.12.003.
Impacto: 50.5. Cuartil: Q1
(1er decil)
Saccardi R., Sanchez-Guijo F.. How can accreditation bodies, such as JACIE or FACT, support centres in getting qualified?. The EBMT/EHA CAR-T Cell Handbook. 7 February 2022. DOI: 10.1007/978-3-030-94353-0_38.
Corral Alaejos Á., Zarzuelo Castañeda A., Jiménez Cabrera S., Sánchez-Guijo F., Otero M.J., Pérez-Blanco J.S.. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia. British Journal of Clinical Pharmacology. April 2022. DOI: 10.1111/bcp.15122.
Impacto: 3.4. Cuartil: Q2
Muntión S., Preciado S., Sánchez-Luis E., Corchete L., Díez-Campelo M., Osugui L., Martí-Chillón G.J., Vidriales M.B., Navarro-Bailón A., De Las Rivas J., Sánchez-Guijo F.. Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells. Therapeutic Advances in Hematology. January-December 2022. DOI: 10.1177/20406207221142137.
Impacto: 3.4. Cuartil: Q2
Lamo-Espinosa J.M., Prósper F., Blanco J.F., Sánchez-Guijo F., Alberca M., García V., González-Vallinas M., García-Sancho J.. Long-term efficacy of autologous bone marrow mesenchymal stromal cells for treatment of knee osteoarthritis. Journal of Translational Medicine. December 2021. DOI: 10.1186/s12967-021-03160-2.
Impacto: 8.44. Cuartil: Q1
Preciado S., Sirerol-Piquer M.ª., Muntión S., Osugui L., Martí-Chillón G.J., Navarro-Bailón A., Sepúlveda P., Sánchez-Guijo F.. Co-administration of human MSC overexpressing HIF-1α increases human CD34<sup>+</sup> cell engraftment in vivo. Stem Cell Research and Therapy. December 2021. DOI: 10.1186/s13287-021-02669-z.
Impacto: 8.079. Cuartil: Q1
Soria-Juan B., Garcia-Arranz M., Llanos Jiménez L., Aparicio C., Gonzalez A., Mahillo Fernandez I., Riera del Moral L., Grochowicz L., Andreu E.J., Marin P., Castellanos G., Moraleda J.M., García-Hernández A.M., Lozano F.S., Sanchez-Guijo F., Villarón E.M., Parra M.L., Yañez R.M., de la Cuesta Diaz A., Tejedo J.R., Bedoya F.J., Martin F., Miralles M., del Rio Sola L., Fernández-Santos M.E., Ligero J.M., Morant F., Hernández-Blasco L., Andreu E., Hmadcha A., Garcia-Olmo D., Soria B.. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial). Trials. December 2021. DOI: 10.1186/s13063-021-05430-2.
Impacto: 2.728. Cuartil: Q4
López R., Martí-Chillón G.J., Blanco J.F., da Casa C., González-Robledo J., Pescador D., Preciado S., Muntión S., Sánchez-Guijo F.. MSCs from polytrauma patients: preliminary comparative study with MSCs from elective-surgery patients. Stem Cell Research and Therapy. December 2021. DOI: 10.1186/s13287-021-02500-9.
Impacto: 8.079. Cuartil: Q1
Vuelta E., Ordoñez J.L., Alonso-Pérez V., Méndez L., Hernández-Carabias P., Saldaña R., Sevilla J., Sebastián E., Muntión S., Sánchez-Guijo F., Hernández-Rivas J.M., García-Tuñón I., Sánchez-Martín M.. CRISPR-Cas9 Technology as a Tool to Target Gene Drivers in Cancer: Proof of Concept and New Opportunities to Treat Chronic Myeloid Leukemia. CRISPR Journal. August 2021. DOI: 10.1089/crispr.2021.0009.
Impacto: 4.321. Cuartil: Q2
Garcia-Gutiérrez V., Luna A., Alonso-Dominguez J.M., Estrada N., Boque C., Xicoy B., Giraldo P., Angona A., Alvarez-Larrán A., Sanchez-Guijo F., Ramírez M.J., Mora E., Vélez P., Rosell A., Colorado Araujo M., Cuevas B., Sagüés M., Cortes M., Encinas M.P., Casado Montero L.F., Moreno Vega M., Serrano L., Gomez V., Garcia-Hernandez C., Lakhwani S., Paz Coll A., de Paz R., Suarez-Varela S., Fernandez-Ruiz A., Perez Lopez R., Ortiz-Fernández A., Jiménez-Velasco A., Steegmann-Olmedillas J.L., Hernández-Boluda J.C.. Safety and efficacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice. Blood Cancer Journal. February 2021. DOI: 10.1038/s41408-021-00420-8.
Impacto: 9.812. Cuartil: Q1
Preciado S., Muntión S., Sánchez-Guijo F.. Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles. Stem Cells. January 2021. DOI: 10.1002/stem.3278.
Impacto: 5.845. Cuartil: Q1
Hernández-Boluda J.C., Pereira A., Alvarez-Larran A., Martín A.A., Benzaquen A., Aguirre L., Mora E., González P., Mora J., Dorado N., Sampol A., García-Gutiérrez V., López-Godino O., Fox M.L., Reguera J.L., Pérez-Encinas M., Pascual M.J., Xicoy B., Parody R., González-Pinedo L., Español I., Avendaño A., Correa J.G., Vallejo C., Jurado M., García-Cadenas I., Osorio S., Durán M.A., Sánchez-Guijo F., Cervantes F., Piñana J.L.. Predicting Survival after Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: Performance of the Myelofibrosis Transplant Scoring System (MTSS) and Development of a New Prognostic Model. Biology of Blood and Marrow Transplantation. December 2020. DOI: 10.1016/j.bbmt.2020.07.022.
Impacto: 5.742. Cuartil: Q1
Stuckey R., Casado L.F., Colomer D., Gómez-Casares M.T., Casas L., García-Gutierrez V., Sastre J.L., Ramírez-Payer Á., Vall-Llovera F., Goñi M.Á., Xicoy B., Godoy A.C., Núñez J., Mora I., Vallansot R., López-Lorenzo J.L., Palomera L., Conesa V., Noya M.S., Sánchez-Guijo F., Peña A., Bautista G., Steegmann J.L.. Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes. Journal of Molecular Diagnostics. October 2020. DOI: 10.1016/j.jmoldx.2020.06.016.
Impacto: 5.568. Cuartil: Q1
Lamo-Espinosa J.M., Blanco J.F., Sánchez M., Moreno V., Granero-Moltó F., Sánchez-Guijo F., Crespo-Cullel Í., Mora G., San Vicente D.D., Pompei-Fernández O., Aquerreta J.D., Núñez-Córdoba J.M., Vitoria Sola M., Valentí-Azcárate A., Andreu E.J., Del Consuelo Del Cañizo M., Valentí-Nin J.R., Prósper F.. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis. Journal of Translational Medicine. 18 September 2020. DOI: 10.1186/s12967-020-02530-6.
Impacto: 5.531. Cuartil: Q2
Soria-Juan B., Escacena N., Capilla-González V., Aguilera Y., Llanos L., Tejedo J.R., Bedoya F.J., Juan V., De la Cuesta A., Ruiz-Salmerón R., Andreu E., Grochowicz L., Prósper F., Sánchez-Guijo F., Lozano F.S., Miralles M., Del Río-Solá L., Castellanos G., Moraleda J.M., Sackstein R., García-Arranz M., García-Olmo D., Martín F., Hmadcha A., Soria B.. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151). Frontiers in Immunology. 2 September 2020. DOI: 10.3389/fimmu.2020.02029.
Impacto: 7.561. Cuartil: Q1
Cabero-Martínez A., Sánchez-Guijo F., López-Corral L., Pérez E., Avendaño A., Baile M., Cabrero M., Martín A.A., Rodríguez A., Pérez B., Peña-Muñoz F., Román L.G., Palomino D., López-Vázquez L., Vidriales M.B., González-Diaz M., Mateos M.V., Caballero M.D.. Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic. Frontiers in Medicine. 26 August 2020. DOI: 10.3389/fmed.2020.00462.
Hochhaus A., Gambacorti-Passerini C., Abboud C., Gjertsen B.T., Brümmendorf T.H., Smith B.D., Ernst T., Giraldo-Castellano P., Olsson-Strömberg U., Saussele S., Bardy-Bouxin N., Viqueira A., Leip E., Russell-Smith T.A., Leone J., Rosti G., Watts J., Giles F.J., Abruzzese E., Akard L.P., Bosi A., Cervantes F., Charbonnier A., Di Raimondo F., Etienne G., Garcia Gutierrez V., Guerci-Bresler A.P., Hjorth-Hansen H., Karsenti J.M., Kelly K.R., Le Coutre P., Martinez Chamorro C., Oehler V.G., Orti Pascual G., Petzer A., Pungolino E., Rege-Cambrin G., Rigal-Huguet F., Roboz G.J., Rousselot P., Sanchez-Guijo F.M., Sanz Santillana G., Schafhausen P., Scheid C., Schmidt S., Specchia G., Steegmann J.L., Stenke L.. Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study. Leukemia. 1 August 2020. DOI: 10.1038/s41375-020-0915-9.
Impacto: 11.528. Cuartil: Q1
(1er decil)
Sánchez-Guijo F., García-Arranz M., López-Parra M., Monedero P., Mata-Martínez C., Santos A., Sagredo V., Álvarez-Avello J.M., Guerrero J.E., Pérez-Calvo C., Sánchez-Hernández M.V., Del-Pozo J.L., Andreu E.J., Fernández-Santos M.E., Soria-Juan B., Hernández-Blasco L.M., Andreu E., Sempere J.M., Zapata A.G., Moraleda J.M., Soria B., Fernández-Avilés F., García-Olmo D., Prósper F.. Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study. EClinicalMedicine. August 2020. DOI: 10.1016/j.eclinm.2020.100454.
Sánchez-Luis E., Joaquín-García A., Campos-Laborie F.J., Sánchez-Guijo F., De las Rivas J.. Deciphering master gene regulators and associated networks of human mesenchymal stromal cells. Biomolecules. April 2020. DOI: 10.3390/biom10040557.
Impacto: 4.879. Cuartil: Q2
Snowden J.A., Saccardi R., Orchard K., Ljungman P., Duarte R.F., Labopin M., McGrath E., Brook N., de Elvira C.R., Gordon D., Poirel H.A., Ayuk F., Beguin Y., Bonifazi F., Gratwohl A., Milpied N., Moore J., Passweg J., Rizzo J.D., Spellman S.R., Sierra J., Solano C., Sanchez-Guijo F., Worel N., Gusi A., Adams G., Balan T., Baldomero H., Macq G., Marry E., Mesnil F., Oldani E., Pearce R., Perry J., Raus N., Schanz U., Tran S., Wilcox L., Basak G.W., Chabannon C., Corbacioglu S., Dolstra H., Kuball J., Mohty M., Lankester A., Montoto S., Nagler A., Styczynski J., Yakoub-Agha I., de Latour R.P., Kroeger N., Brand R., de Wreede L.C., van Zwet E., Putter H.. Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7). Bone Marrow Transplantation. 1 April 2020. DOI: 10.1038/s41409-019-0740-9.
Impacto: 5.483. Cuartil: Q1
Snowden J.A., Saccardi R., Orchard K., Ljungman P., Duarte R.F., Labopin M., McGrath E., Brook N., de Elvira C.R., Gordon D., Poirel H.A., Ayuk F., Beguin Y., Bonifazi F., Gratwohl A., Milpied N., Moore J., Passweg J., Rizzo J.D., Spellman S.R., Sierra J., Solano C., Sanchez-Guijo F., Worel N., Gusi A., Adams G., Balan T., Baldomero H., Macq G., Marry E., Mesnil F., Oldani E., Pearce R., Perry J., Raus N., Schanz U., Tran S., Wilcox L., Basak G.W., Chabannon C., Corbacioglu S., Dolstra H., Kuball J., Mohty M., Lankester A., Montoto S., Nagler A., Styczynski J., Yakoub-Agha I., de Latour R.P., Kroeger N., Brand R., de Wreede L.C., van Zwet E., Putter H.. Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation. 1 April 2020. DOI: 10.1038/s41409-019-0718-7.
Impacto: 5.483. Cuartil: Q1
Garcia-Arranz M., Garcia-Olmo D., Herreros M.D., Gracia-Solana J., Guadalajara H., de la Portilla F., Baixauli J., Garcia-Garcia J., Ramirez J.M., Sanchez-Guijo F., Prosper F.. Autologous adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long-term follow-up. Stem Cells Translational Medicine. 1 March 2020. DOI: 10.1002/sctm.19-0271.
Impacto: 6.94. Cuartil: Q1
Sharrack B., Saccardi R., Alexander T., Badoglio M., Burman J., Farge D., Greco R., Jessop H., Kazmi M., Kirgizov K., Labopin M., Mancardi G., Martin R., Moore J., Muraro P.A., Rovira M., Sormani M.P., Snowden J.A., McGrath E., Bambi F., Sanchez-Guijo F., Worel N., Badolglio M., Abinun M., Arnold R., Brierley C., Castilla-Llorente C., Cooper N., Daikeler T., del Papa N., Finke J., Reax R., Hagglund H., Henes J., Hiepe F., Kiely D., Mancardi G., Marjanovic Z., Martin T., Ma D., Miller P., Oliveira M.C., Polushin A., Onida F., Simoes B., Puyade M., Resnick I., Saif M., Sakellari I., Snarski E., Scherer H.U., Sossa C., de Vries-Bouwstra J., Wulffraat N., Zaccara E.. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone Marrow Transplantation. 1 February 2020. DOI: 10.1038/s41409-019-0684-0.
Impacto: 5.483. Cuartil: Q1
Yakoub-Agha I., Chabannon C., Bader P., Basak G.W., Bonig H., Ciceri F., Corbacioglu S., Duarte R.F., Einsele H., Hudecek M., Kersten M.J., Köhl U., Kuball J., Mielke S., Mohty M., Murray J., Nagler A., Robinson S., Saccardi R., Sanchez-Guijo F., Snowden J.A., Srour M., Styczynski J., Urbano-Ispizua A., Hayden P.J., Kröger N.. Management of adults and children undergoing chimeric antigen receptor T-cell therapy: Best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Haematologica. 31 January 2020. DOI: 10.3324/haematol.2019.229781.
Impacto: 9.941. Cuartil: Q1
(1er decil)
Sánchez-Guijo F., García-Olmo D., Prósper F., Martínez S., Zapata A., Fernández-Avilés F., Toledo-Aral J.J., Torres M., Fariñas I., Badimón L., Labandeira-García J.L., García-Sancho J., Moraleda J.M.. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research. Cytotherapy. January 2020. DOI: 10.1016/j.jcyt.2019.11.001.
Impacto: 5.414. Cuartil: Q1
Romo-González M., Moreno-Paz S., García-Hernández V., Sánchez-Guijo F., Hernández-Hernández Á.. Inhibition of xanthine oxidoreductase enhances the potential of tyrosine kinase inhibitors against chronic myeloid leukemia. Antioxidants. January 2020. DOI: 10.3390/antiox9010074.
Impacto: 6.312. Cuartil: Q1
(1er decil)
Martin-Rufino J.D., Espinosa-Lara N., Osugui L., Sanchez-Guijo F.. Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?. Frontiers in Bioengineering and Biotechnology. 5 November 2019. DOI: 10.3389/fbioe.2019.00308.
Impacto: 3.644. Cuartil: Q2
Preciado S., Muntión S., Corchete L.A., Ramos T.L., de la Torre A.G., Osugui L., Rico A., Espinosa-Lara N., Gastaca I., Díez-Campelo M., del Cañizo C., Sánchez-Guijo F.. The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34<sup>+</sup> Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability. Stem Cells. 1 October 2019. DOI: 10.1002/stem.3032.
Impacto: 6.022. Cuartil: Q1
Jiménez-Solas T., López-Cadenas F., Aires-Mejía I., Caballero-Berrocal J.C., Ortega R., Redondo A.M., Sánchez-Guijo F., Muntión S., García-Martín L., Albarrán B., Alonso J.M., Del Cañizo C., Hernández-Hernández Á., Díez-Campelo M.. Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity. British Journal of Haematology. 1 October 2019. DOI: 10.1111/bjh.16013.
Impacto: 5.518. Cuartil: Q1
Carrillo-Cruz E., García-Lozano J.R., Marquez-Malaver F.J., Sanchez-Guijo F.M., Cuadrado I.M., Coll C.F., Valcarcel D., Lopez-Godino O., Cuesta M., Parody R., Lopez-Corral L., Alcoceba M., Caballero-Velazquez T., Rodríguez-Gil A., Bejarano-García J.A., Lopes Ramos T., Perez-Simon J.A.. Vitamin D modifies the incidence of graft-versus-host disease after allogeneic stem cell transplantation depending on the Vitamin D Receptor (VDR) polymorphisms. Clinical Cancer Research. 1 August 2019. DOI: 10.1158/1078-0432.CCR-18-3875.
Impacto: 10.107. Cuartil: Q1
(1er decil)
García-Tuñón I., Alonso-Pérez V., Vuelta E., Pérez-Ramos S., Herrero M., Méndez L., Hernández-Sánchez J.M., Martín-Izquierdo M., Saldaña R., Sevilla J., Sánchez- Guijo F., Hernández-Rivas J.M., Sánchez-Martín M.. Splice donor site sgRNAs enhance CRISPR/ Cas9-mediated knockout efficiency. PLoS ONE. May 2019. DOI: 10.1371/journal.pone.0216674.
Impacto: 2.74. Cuartil: Q2
Rivera D., Bastida J.M., Lopez-Corral L., Sanchez-Guijo F., Cabrero M., Martin A., Perez E., Lopez-Parra M., Avendaño A., Veiga A., Baile M., Arratibel N., Carrillo J., Vazquez L., Caballero M.D., Gonzalez-Porras J.R.. Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplantation. 1 May 2019. DOI: 10.1038/s41409-018-0368-1.
Impacto: 4.725. Cuartil: Q1
Martínez-Carrasco R., Sánchez-Abarca L.I., Nieto-Gómez C., Martín García E., Sánchez-Guijo F., Argüeso P., Aijón J., Hernández-Galilea E., Velasco A.. Subconjunctival injection of mesenchymal stromal cells protects the cornea in an experimental model of GVHD. Ocular Surface. April 2019. DOI: 10.1016/j.jtos.2019.01.001.
Impacto: 12.336. Cuartil: Q1
(1er decil)
Blanco J.F., Villarón E.M., Pescador D., Da Casa C., Gómez V., Redondo A.M., López-Villar O., López-Parra M., Muntión S., Sánchez-Guijo F.. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: Results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Research and Therapy. 22 February 2019. DOI: 10.1186/s13287-019-1166-4.
Impacto: 5.116. Cuartil: Q1
Pérez-Fernández A., López-Ruano G., Prieto-Bermejo R., Ijurko C., Díez-Campelo M., Sánchez-Guijo F., Hernández-Hernández Á.. SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: An alternative approach against acute myeloid leukemia. Journal of Experimental and Clinical Cancer Research. 14 February 2019. DOI: 10.1186/s13046-019-1097-z.
Impacto: 7.068. Cuartil: Q1
Colom-Fernández B., Kreutzman A., Marcos-Jiménez A., García-Gutiérrez V., Cuesta-Mateos C., Portero-Sainz I., Pérez-García Y., Casado L.F., Sánchez-Guijo F., Martínez-López J., Ayala R.M., Boqué C., Xicoy B., Montero I., Soto C., Paz R., Silva G., Vega-Piris L., Steegmann J.L., Muñoz-Calleja C.. Immediate effects of dasatinib on the migration and redistribution of naïve and memory lymphocytes associated with lymphocytosis in chronic myeloid leukemia patients. Frontiers in Pharmacology. 2019. DOI: 10.3389/fphar.2019.01340.
Impacto: 4.225. Cuartil: Q1
Soria-Juan B., Escacena N., Capilla-González V., Aguilera Y., Llanos L., Tejedo J.R., Bedoya F.J., Juan V., De La Cuesta A., Ruiz-Salmerón R., Andreu E., Grochowicz L., Prósper F., Sánchez-Guijo F., Lozano F.S., Miralles M., Del Río-Solá L., Castellanos G., Moraleda J.M., Sackstein R., García-Arranz M., García-Olmo D., Martín F., Hmadcha A., Soria B.. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus. Frontiers in Immunology. 2019. DOI: 10.3389/fimmu.2019.01151.
Impacto: 5.085. Cuartil: Q1
Thielen F.W., Blommestein H.M., Oosten L.E.M., Calkoen F.G., Lankester A.C., Zwaginga J.J., Le Blanc K., Redondo A., Sánchez-Guijo F., Algeri M., Locatelli F., Fibbe W.E., Uyl-de Groot C.A.. Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model. European Journal of Haematology. November 2018. DOI: 10.1111/ejh.13158.
Impacto: 2.217. Cuartil: Q3
Trento C., Bernardo M.E., Nagler A., Kuçi S., Bornhäuser M., Köhl U., Strunk D., Galleu A., Sanchez-Guijo F., Gaipa G., Introna M., Bukauskas A., Le Blanc K., Apperley J., Roelofs H., Van Campenhout A., Beguin Y., Kuball J., Lazzari L., Avanzini M.A., Fibbe W., Chabannon C., Bonini C., Dazzi F.. Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. November 2018. DOI: 10.1016/j.bbmt.2018.07.015.
Impacto: 3.599. Cuartil: Q2
Osorio S., Escudero-Vilaplana V., Gómez-Centurión I., Pérez-López R., Ayala R., Vall-Llovera F., García-Gutierrez V., Gómez Casares M.T., González San Miguel J.D., Hernández-Rivas J.Á., Sánchez-Guijo F., Martínez-García A.B., Villalón L., Conesa-García V., Rodriguez A., Casado F., Garcia-Gonzalez X., Sáez Perdomo M.N., Baños Ú., Steegmann J.L.. Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?. Annals of Hematology. 1 November 2018. DOI: 10.1007/s00277-018-3413-7.
Impacto: 2.85. Cuartil: Q3
Hernández-Boluda J.C., Pereira A., Pastor-Galán I., Alvarez-Larrán A., Savchuk A., Puerta J.M., Sánchez-Pina J.M., Collado R., Díaz-González A., Angona A., Sagüés M., García-Gutiérrez V., Boqué C., Osorio S., Vallansot R., Palomera L., Mendizábal A., Casado L.F., Pérez-Encinas M., Pérez-López R., Ferrer-Marín F., Sánchez-Guijo F., García C., Heras N.d.l., López-Lorenzo J.L., Cervantes F., Steegmann J.L.. Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients. Blood Cancer Journal. 1 October 2018. DOI: 10.1038/s41408-018-0125-0.
Impacto: 7.895. Cuartil: Q1
(1er decil)
Lamo-Espinosa J.M., Mora G., Blanco J.F., Granero-Moltó F., Núñez-Córdoba J.M., López-Elío S., Andreu E., Sánchez-Guijo F., Aquerreta J.D., Bondía J.M., Valentí-Azcárate A., Consuelo del Cañizo M., Villarón E.M., Valentí-Nin J.R., Prósper F.. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: Long-term follow up of a multicenter randomized controlled clinical trial (phase I/II). Journal of Translational Medicine. 31 July 2018. DOI: 10.1186/s12967-018-1591-7.
Impacto: 4.098. Cuartil: Q2
Martin-Rufino J.D., Lozano F.S., Redondo A.M., Villaron E.M., Rueda R., Fernandez-Samos R., Sanchez-Guijo F.. Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease). Stem Cell Research and Therapy. 30 May 2018. DOI: 10.1186/s13287-018-0901-6.
Impacto: 4.627. Cuartil: Q1
Ibáñez-Fonseca A., Ramos T.L., González de Torre I., Sánchez-Abarca L.I., Muntión S., Arias F.J., del Cañizo M.C., Alonso M., Sánchez-Guijo F., Rodríguez-Cabello J.C.. Biocompatibility of two model elastin-like recombinamer-based hydrogels formed through physical or chemical cross-linking for various applications in tissue engineering and regenerative medicine. Journal of Tissue Engineering and Regenerative Medicine. March 2018. DOI: 10.1002/term.2562.
Impacto: 3.319. Cuartil: Q2
Preciado S., Muntión S., Rico A., Pérez-Romasanta L.A., Ramos T.L., Ortega R., Borrajo J., Corchete L.A., Rodríguez C., Díez-Campelo M., Sánchez-Abarca L.I., Del Cañizo M.C., Sánchez-Guijo F.. Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability. Biology of Blood and Marrow Transplantation. March 2018. DOI: 10.1016/j.bbmt.2017.11.007.
Impacto: 3.599. Cuartil: Q2
Blanco J., García-Briñon J., Benito-Garzón L., Pescador D., Muntión S., Sánchez-Guijo F.. Human bone marrow mesenchymal stromal cells promote bone regeneration in a xenogeneic rabbit model: A preclinical study. Stem Cells International. 2018. DOI: 10.1155/2018/7089484.
Ramos T.L., Sánchez-Abarca L.I., Rosón-Burgo B., Redondo A., Rico A., Preciado S., Ortega R., Rodríguez C., Muntión S., Hernández-Hernández Á., De Las Rivas J., González M., González Porras J.R., Del Cañizo C., Sánchez-Guijo F.. Mesenchymal stromal cells (MSC) from JAK2<sup>+</sup> myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis. PLoS ONE. August 2017. DOI: 10.1371/journal.pone.0182470.
Impacto: 2.766. Cuartil: Q1
Pescador D., Ibáñez-Fonseca A., Sánchez-Guijo F., Briñón J.G., Arias F.J., Muntión S., Hernández C., Girotti A., Alonso M., del Cañizo M.C., Rodríguez-Cabello J.C., Blanco J.F.. Regeneration of hyaline cartilage promoted by xenogeneic mesenchymal stromal cells embedded within elastin-like recombinamer-based bioactive hydrogels. Journal of Materials Science: Materials in Medicine. 1 August 2017. DOI: 10.1007/s10856-017-5928-1.
Impacto: 2.448. Cuartil: Q2
Martínez-Carrasco R., Sánchez-Abarca L.I., Nieto-Gómez C., García E.M., Ramos T.L., Velasco A., Sánchez-Guijo F., Aijón J., Hernández-Galilea E.. Assessment of dry eye in a GVHD murine model: Approximation through tear osmolarity measurement. Experimental Eye Research. 1 January 2017. DOI: 10.1016/j.exer.2016.11.004.
Impacto: 3.152. Cuartil: Q1
Cervantes F., Correa J.G., Pérez I., García-Gutiérrez V., Redondo S., Colomer D., Jiménez-Velasco A., Steegmann J.L., Sánchez-Guijo F., Ferrer-Marín F., Pereira A., Osorio S.. Imatinib dose reduction in patients with chronic myeloid leukemia in sustained deep molecular response. Annals of Hematology. 1 January 2017. DOI: 10.1007/s00277-016-2839-z.
Impacto: 2.845. Cuartil: Q2
Ramos T.L., Sánchez-Abarca L.I., Redondo A., Hernández-Hernández Á., Almeida A.M., Puig N., Rodríguez C., Ortega R., Preciado S., Rico A., Muntión S., Porras J.R.G., Del Cañizo C., Sánchez-Guijo F.. HDAC8 overexpression in mesenchymal stromal cells from JAK2<sup>+</sup> myeloproliferative neoplasms: A new therapeutic target?. Oncotarget. 2017. DOI: 10.18632/oncotarget.15969.
Caballero-Velazquez T., Montero I., Sanchez-Guijo F., Parody R., Saldana R., Valcarcel D., Lopez-Godino O., Coll C.F.I., Cuesta M., Carrillo-Vico A., Sanchez-Abarca L.I., Lopez-Corral L., Marquez-Malaver F.J., Perez-Simon J.A.. Immunomodulatory effect of Vitamin D after allogeneic stem cell transplantation: Results of a prospective multicenter clinical trial. Clinical Cancer Research. 1 December 2016. DOI: 10.1158/1078-0432.CCR-16-0238.
Impacto: 9.619. Cuartil: Q1
(1er decil)
Blanco B., Herrero-Sánchez M.d.C., Rodríguez-Serrano C., García-Martínez M.L., Blanco J.F., Muntión S., García-Arranz M., Sánchez-Guijo F., del Cañizo C.. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting. European Journal of Haematology. 1 December 2016. DOI: 10.1111/ejh.12765.
Impacto: 2.653. Cuartil: Q2
Roson-Burgo B., Sanchez-Guijo F., Del Cañizo C., De Las Rivas J.. Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling. BMC Genomics. 21 November 2016. DOI: 10.1186/s12864-016-3230-0.
Impacto: 3.729. Cuartil: Q1
Parody R., López-Corral L., Lopez-Godino O., Martinez C., Martino R., Solano C., Barba P., Caballero D., García-Cadenas I., Piñana J.L., Marquez-Malaver F.J., Vazquez L., Esquirol A., Boluda J.C.H., Sanchez-Guijo F., Pérez-Simon J.A.. GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: Results of a multicenter study. Bone Marrow Transplantation. 1 November 2016. DOI: 10.1038/bmt.2016.163.
Impacto: 3.874. Cuartil: Q2